Diaglizid (gliclazide) tablets 0.08 g. №60

$14.00

Manufacturer: Ukraine

Purpose: Stimulates insulin release for type 2 diabetes management.

SKU: MED57737 Category:

Description

Diaglizid (gliclazide) tablets 0.08 g. №60

Ingredients

Diaglizid tablets contain 0.08 g of gliclazide as the active ingredient.

Dosage

The recommended dosage of Diaglizid tablets is determined by the healthcare provider based on individual needs. Typically, the usual starting dose is 80 mg once daily with breakfast.

Indications

Diaglizid tablets are indicated for the treatment of type 2 diabetes mellitus to help lower blood sugar levels.

Contraindications

Do not use Diaglizid tablets if you have a known allergy to gliclazide or sulfonylureas, or if you have type 1 diabetes.

Directions

Take Diaglizid tablets exactly as prescribed by your healthcare provider. Swallow the tablet whole with a glass of water, usually once daily with breakfast.

Scientific Evidence

Gliclazide, the active ingredient in Diaglizid tablets, is a sulfonylurea that works by stimulating the release of insulin from the pancreas, thereby lowering blood sugar levels. Several studies have demonstrated the efficacy of gliclazide in controlling blood glucose levels in patients with type 2 diabetes.

Additional Information

It is important to monitor blood sugar levels regularly while taking Diaglizid tablets to ensure optimal control of diabetes. Additionally, consult your healthcare provider before starting or stopping any medication to avoid potential interactions.

Research has shown that gliclazide not only helps in controlling blood sugar levels but also has beneficial effects on cardiovascular outcomes in diabetic patients. A study by Standl et al. (2010) demonstrated that gliclazide treatment was associated with a reduced risk of cardiovascular events compared to other sulfonylureas.